The present study was designed to investigate potential liver damage due to acrylonitrile in Streptozotocin induced diabetes in rats. Twentyfour rats were divided into 4 treatment groups. Nondiabetic control rat receiving distilled water, non-diabetic rat receiving acrylonitrile aqueous solution (10 mg/kg/day), diabetic control rat receiving distilled water and diabetic rat receiving acrylonitrile aqueous solution. All groups received the treatment for 4 weeks. The animals were assessed for hepatoxicity markers in serum, oxidative stress markers, CYP2E1 activity and cyanide formation in tissues. Acrylonitrile signifi cantly elevated serum aminotransferase, alanine aminotransferase, total bilirubin levels, triglycerides and total cholesterol in diabetic groups as compared to normal control group. Antioxidant markers like glutathione showed signifi cant decline while a signifi cant increase in malondialdehyde, superoxide dismutase and catalase in diabetic rats treated with acrylonitrile. CYP2E1 activity was observed in acrylonitrile -exposed nondiabetic and diabetic groups as compared to control. Cyanide formation was raised in both the nondiabetic and diabetic groups as compared to control group. Acrylonitriles can produce acute hepatic injury, induction of diabetes mellitus type II, and accomplish the CYP2E1 enzyme which sequentially leads to generation of oxidative stress and its metabolic product-cyanide that may potentiate the oxidative stress posing more deleterious eff ect.
Introduction
A crylonitrile (ACN) is extensively utilized in the manufacturing of several industrial products like nitrile rubbers, plastics, synthetic fi bers and fumigants of insect killers for grain [1] . In addition, it also fi nds use as an intermediate in the synthesis of antioxidants, surface coatings, adhesives, and dyes [1] . Acrylonitrile is also used in the manufacturing of dialysis tubing possessing high permeability [2] , and cigarette smoke [3] . Metabolism of ACN in human is through two main metabolic pathways (i) Glutathione conjugation and (ii) oxidation by Cytochrome P450. The conjugation of ACN with glutathione leads mainly to produce 2-cyanoethyl mercapropuric acid (N-acetyl-S-2-cyano ethyl cysteine [4, 5] . Cytochrome P-450 oxidation yield 2-cyanoethyleneoxideandcyanide (CN) that undergoes conjugation with reduced glutathione to yield multiple metabolites including cyanide and thiocyanate [6] .
It was observed that ACN induced acute toxicity in rats is characterized by damage to the tissues of vital organs which includes liver, lung, brain and kidney [7] [8] [9] [10] [11] [12] , stomach [13] , and lysis of adrenal cortex [14] .
One of the hallmarks of diabetes is the requirement of multiple medications with longterm administration which may consequently lead to unavoidable complications [6, 15] . A recent study highlighted that in drug induced diabetes in rats as well as normal rats, the level of enzymes responsible for hepatic drug metabolism was reduced. The decreased enzymes included glutathione reductase, glutathione peroxidase, p-nitrophenol glucuronosyl transferase, arylsulphotransferase I and II [16] .
In contrast, Sindhu et al. [17] studied the expression of major isozymes of CYP450 in Streptozotocin (STZ) induced diabetes with simultaneous treatment with insulin. They reported upregulation of microsomal activity of CYP1B, CYP1A, heme oxygenase (HO)-2 proteins and CYP1A2-dependent 7-ethoxyresorufi n O-demethylase (EROD) in the diabetic rats. The expression of CYP1A, CYP1B1 and HO-2 had been improved by insulin and there was a noticeable induction in CYP2B1 and 2E1 proteins in diabetic animals. Treatment with insulin caused total and partial restorations of CYP2E1 and CYP2B1 proteins, respectively. Similarly, insulin could in part improve CYP2C11 protein while diabetic state decreased it by > 99%. The decisive disclosure of this study is that overall changes in the expression of diff erent isozymes of CYP450 exist in diabetic rats which can be evidently ameliorated by insulin therapy [18, 19] . This study was performed to assess the potential liver damaging eff ect of ACN and enzyme induction per se in diabetes mellitus (DM) leading to supplementary deleterious eff ect in the presence of DM.
Materials and Methods

Animals
Male Sprague Dawley rats weighing 150-200 g were obtained from the animal facility of King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. The animals were provided with standard pellet diet and water ad libitum. They were kept at typical conditions (room temperature of 25 ± 2°C, 45-55% relative humidity and 12 h dark/light cycle). Procedures involving animals and their care were conducted in conformity with the institutional guidelines of King Abdulaziz University, Jeddah, Saudi Arabia.
Induction of Diabetes
Type 2 diabetes was induced by injecting freshly prepared STZ, dissolved in cold citrate buff er (0.1M), pH 4.5 at dose (35 mg/kg) as a single intraperitoneal injection to overnight-fasted rats. The rats were tested for successful induction of diabetes after 2, 5 and 8 days of STZ injection by determining fasting blood glucose levels. Rats with blood glucose levels ranging between 250-350 mg/dl were selected [18] . Fasting blood samples were collected from the tail vein of the overnight (12-15 h) fasting rats. The blood glucose level was analyzed using One Touch Ultra (LifeScan/Johnson & Johnson, Milpitas, CA, USA).
Animal Treatments
Twenty-four rats were divided into four groups (six animals per group). Groups 1 and 2 were normal healthy animals while groups 3 and 4 were diabetic rats. Briefl y, group 1 served as negative control receiving only distilled water for 4 weeks. Group 2 was administered aqueous solution of ACN orally (10 mg/ kg/d) for 4 weeks. This dose represents one tenth of oral LD50 of ACN in rats [19] . Group 3 served as a diabetic group receiving only distilled water for 4 weeks. Group 4 served as diabetic group exposed to ACN under the same conditions as group 2 (10 mg/kg/d for 4 weeks).
Preparation of Tissue and Serum Samples
Blood samples were collected from the retro-orbital plexus followed by centrifugation at 3000g for 15 min for serum separation [19] . The serum was stored at -80°C until the assessment of hepatotoxicity markers. Rats were sacrifi ced and liver tissues were dissected and homogenized at 1:5 (w/v) with the phosphate-buff ered saline (PBS) pH 7.4.
Evaluation of Hepatotoxicity Markers
Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), total cholesterol, triglycerides and total bilirubin were assessed colorimetrically using commercially available kits (Spectrum Diagnostics, Cairo, Egypt). Liver index was calculated as liver weight/ body weight X 100.
Assessment of Oxidative Stress Markers
Hepatic tissues homogenate was used for determination of lipid peroxides by assessing the level of thiobarbituric acid reactive substances (TBARS) expressed as nmol malondialdehyde (MDA)/gram tissue. Reduced glutathione (GSH) level and superoxide dismutase (SOD) and catalase (CAT) activities were determined in liver tissues using commercially available kits (Biodiagnostics, Cairo, Egypt) [18] . The protein content in the hepatic homogenates was determined according to the method of Lowry et al. [19, 20] using bovine serum albumin as a standard.
Cytochrome P450 2E1 (CYP2E1) Activity
Colorimetric assay was used to measure CYP2E1 activity through hydroxylation of p-nitrophenol according to Chang et al. [21] . Briefl y the assay monitors the formation of "p-nitrocatechol" from "p-nitrophenol" due to the enzymatic action of CYP2E1. Then, the product "p-nitrocatechol" was acidifi ed by trichloro acetic acid followed by neutralization with 2N NaOH and then assessed colorimetrically at wavelength 535 nm.
Cyanide Determination
CN − concentration in the hepatic homogenates (10% w/v in PBS) was determined electrochemically as described by Abreu and Ahmed [22] . Briefl y, 2 mL of the homogenate was added to 2 mL 4 N H 2 SO 4 contained in the outer chamber of a Conway microdiff usion cell (Thomas Scientifi c, Swedesboro, NJ USA). The inner chamber contained 2 mL 0.1 N NaOH. Silicone grease was used for sealing the cells with a glass cover and rotating at 0.8×g for 2h. In the inner chamber of the Conway microdiff usion cell Silver sulfi de electrode model 9416BN and double junction reference electrode model 9202 (Orion Research Inc., Cambridge, MA, USA) were placed to which 50 μL KAg (CN) 2 indicator solution was added. The indicator solution was prepared by adding 1.25M Na 2 HPO 4 , 0.55M NaOH, and 0.46 mM KAg (CN) 2 to make up fi nal volume of 100 mL. Millivolts were determined using a Hanna pH meter (model 8417). Serially diluted standards of NaCN were used to construct the standard curve. The CN − content of samples was determined from this standard curve.
Statistical Analysis
The results were expressed as mean ± standard error of measurement and statistically analyzed using oneway analysis of variance (ANOVA) followed by student Tukey-Kramer post hoc test. P values ≤ 0.05 were considered signifi cant. The percentage of change was calculated as follows:
Percentage Change = (treated control)/(control) ×100.
Results
Hepatotoxicity Markers
As shown in Figure 1A , normal rats exposed to ACN have shown more than a 3-fold increase in serum AST level, compared to the control group. The same eff ect was obtained in diabetic rats, where AST level was elevated by a comparable extent. However, when diabetic rats were exposed to ACN, the combined eff ect was greatly higher, resulting in about a 5-fold increase in serum AST level, compared to the control group. Interestingly, exposure of diabetic group to ACN signifi cantly elevated AST by about 57% and 67%, when compared to ACN-exposed nondiabetic and diabetic groups, respectively. It is worth noting that analogous patterns of eff ects were observed for ALT and total bilirubin levels. There were signifi cant and comparable increases in their serum levels in ACN-exposed and diabetic rats, compared to the control group. Additionally, exposing diabetic animals to ACN markedly increased serum levels of ALT and total bilirubin, compared to all other groups, as shown in Figure 1B , and 1C, respectively.
Regarding serum triglycerides level, ACN-exposed nondiabetic exposed animals failed to show any signifi cant change when compared to the control group, as shown in Figure 1D . However, diabetic rats have shown a signifi cant rise of serum triglycerides by about 42%, compared to the control. This eff ect was further magnifi ed when diabetic animals were exposed to ACN, where serum triglycerides level was signifi cantly elevated by about 60% compared to the control and 13.2% compared to the diabetes-alone group. A similar pattern of observations was obtained Acrylonitrile Liver Toxicity in STZ Diabetic Rats S.E. Alharthi with total cholesterol level. As detected in Figure 1E , no change was observed in ACN-exposed nondiabetic group, with a signifi cant elevation in diabetic animals by 69%, compared to the control group. Importantly, diabetic animals exposed to ACN have shown more than a 2-fold increase of serum level of total cholesterol.
Oxidative Stress Markers
Oxidative status was evaluated by measuring the hepatic content of GSH as an antioxidant marker and MDA concentration as a lipid peroxidation marker, in addition to the enzymatic activities of two antioxidant enzymes: SOD and CAT, in hepatic tissue homogenates. As shown in Figure 2A , ACN caused a signifi cant depletion of GSH by about 50% compared to the control group. Diabetes itself induced oxidative imbalance as manifested by a signifi cant reduction of GSH content by about 27% compared to the control. However, when diabetes was combined with ACN exposure, the net eff ect was markedly signifi cant from all tested groups, as GSH was reduced by about 60% compared to the control. These observations were further reinforced by measuring MDA as lipid peroxidation marker, as demonstrated in Figure 2B . Animals exposed to ACN have signifi cantly increased MDA concentration to almost two times the control value. In diabetic rats, MDA concentration was elevated by about 60% when compared to the control group. However, exposure of diabetic rats to ACN resulted in an amplifi ed eff ect on MDA concentration that was signifi cantly higher than 
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Concerning SOD enzymatic activity, exposure of normal animals to ACN signifi cantly decreased SOD activity by about 41% compared to the control, as shown in Figure 3A . A similar eff ect was detected in the diabetic group, where SOD activity was dropped by an analogous degree. However, the net eff ect of diabetes and ACN exposure was much more signifi cant than all other groups; being able to reduce SOD activity to about 14% of the control value. Parallel to these fi ndings, CAT activity was decreased in a comparable pattern, as shown in Figure 3B . Acrylonitrile-exposed nondiabetic and diabetic groups have demonstrated about a 30% reduction compared to the control group, while in diabetic animals exposed to ACN, a signifi cant decrease of CAT activity by about 72% of the control value was observed.
Cytochrome P4502E1 (CYP2E1) Activity
As shown in Figure 4 , CYP2E1 activity was signifi cantly increased by 29% and 20% in ACN-exposed nondiabetic and diabetic groups, respectively, compared to the control. No signifi cant diff erence was detected between these two groups; ACN-exposed non-diabetic and diabetics. It is worth mentioning that exposure to ACN in diabetic rats markedly activated CYP2E1 by about 82% compared to the control group. Interestingly, this eff ect was also signifi cant in comparison to the other groups (ACN-exposed non-diabetic and diabetic groups).
Cyanide Formation
Cyanide concentration in the hepatic homogenates was assayed electrochemically and results were illustrated in Figure 5 . In the absence of ACN, cyanide formation was negligible in both the control and diabetic groups. As a result of ACN exposure in nondiabetic rats, its metabolic product -cyanide -was produced in a signifi cant amount (> 20-fold), compared to the control. Moreover, exposure to ACN in diabetic 
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Discussion
Several worldwide research studies have revealed that environmental pollutants potentially act as a contributing determinant for DM. Chronic exposure to the pesticides and herbicides often creates disturbance in glucose metabolism and is also capable of inducing insulin resistance [23, 24] . Moreover, organic pollutants are lipophilic in nature and the likelihood of obesity potentiates the ability of the body to store these toxic chemicals which in turn are profi cient in inducing insulin resistance as well as DM type II (DM2) in a dose and perhaps time dependent manner [25, 26] .
The results of this study decisively illustrate that ACN alone quite signifi cantly produces acute injury to hepatocytes of rats as revealed by an increased level of not only liver enzymes but also the serum levels of total cholesterol and triglycerides. It is noteworthy that these parameters were also augmented in a similar manner in drug induced diabetic rats, thus confi rming the detrimental eff ect of both ACN and DM2 in producing acute hepatotoxicity. Seemingly, diabetic animals exposed to ACN have shown a marked increase in all the parameters of liver injury in comparison to ACN alone treated rats and untreated drug induced diabetic rats, thus confi rming the fi nding so for the relevant studies [22] [23] [24] [25] [26] .
In addition, a remarkable feature in DM2 is enhancement of oxidative stress which is in turn responsible for several chronic degenerative complications. The prime objective of the treatment of DM is to prevent several chronic degenerative complications which is basically due to the phenomenon of oxidative stress which in turn occurs as a result of excessive formation of free radicals suffi cient enough to overcome the detoxifi cation capacity of the cellular antioxidant system [27, 28] . A well-established fact in DM is the vulnerability of hyperglycemia as a driving force for the development of well-known diabetic complications [29] . This study remarkably revealed the substantial eff ect of ACN as well as drug induced DM2 on the parameters of both enzymatic antioxidants which includes depressant activity on the hepatic content of GSH as an antioxidant marker and signifi cant amplifi cation of lipid peroxidation MDA and similar a depressant eff ect on non-enzymatic antioxidants such as SOD enzymatic activity and CAT activity on both hepatic tissue homogenate of normal and STZinduced diabetic rats.. Furthermore, these observations were enforced by a marked increase in MDA as lipid peroxidation marker. However, a concomitant eff ect was revealed on non-enzymatic antioxidants i.e., SOD and CAT. These results are fairly consistent with the observations revealed in several studies [27, 28] .
Several studies demonstrated signifi cant elevation of CYP2E1 enzymes in diff erent liver disorders and DM [14, 30, 31] . In addition it was also demonstrated that the expression of CYP1A2 and CYP2E1 was observed to be signifi cantly higher in diabetic rats in comparison to normal rats [32, 33] .
In in this current study it was noteworthy that CYP2E1 activity was appreciably augmented in both ACN-exposed nondiabetic and diabetic groups, respectively, compared to the control group. However, exposure to ACN in diabetic rats markedly amplifi ed the levels of CYP2E1 enzyme, which has directed the observation of potentiation of harmful eff ect of ACN in DM.
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S.E. Alharthi rats signifi cant enhancement of cyanide was observed in comparison to the control group. Likewise, exposure to ACN in diabetic rats obviously caused further augmentation in cyanide production, compared to the control group, an eff ect that was also signifi cant in comparison to ACN-exposed nondiabetic rats. These fi ndings are splendidly sustained by the fi ndings of several studies illustrating the oxidation of ACN by CYP2E1, which subsequently gets converted to 2-cyanoethyleneoxide (CEO), which is well known as a reactive and a relatively long-lived epoxide [34] . CEO gets in turn metabolized leading to the release of CNreactive and a relatively long-lived epoxide [38] .
Interestingly, the present study results of augmentation of cyanide production by ACN is further authenticated by the studies demonstrating that CN might enhance ACN induced oxidative stress by increasing hydroperoxide generation and lipid peroxidation [35] .
Conclusion
Acrylonitrile, a well-known industrial pollutant, is capable of producing acute hepatic injury as well as induction of DM2. In addition, it can also saturation of the CYP2E1 enzyme which sequentially leads to generation of oxidative stress and its metabolic product, cyanide, that poses additional deleterious eff ects due to potentiation of the oxidative stress. 
